Group 1 - Bohai Chemical announced the termination of its major asset restructuring plan, which involved the sale of 100% equity in Bohai Petrochemical and the acquisition of control over Taida New Materials, due to a lack of consensus on key terms among the parties involved [1][4] - The restructuring effort aimed to divest the loss-making propane dehydrogenation (PDH) business and transition towards fine chemicals, as the company faces ongoing challenges with demand and supply, resulting in continuous losses [4] - Bohai Chemical's revenue for 2023, 2024, and the first three quarters of 2025 were reported at 3.225 billion, 4.784 billion, and 2.809 billion respectively, with net profits of -522 million, -632 million, and -579 million [4] Group 2 - Nanjing Shanglv announced the termination of its acquisition of 100% equity in Nanjing Huangpu Hotel due to changes in market conditions [5][9] - The restructuring process for Nanjing Shanglv began in May 2024 and faced multiple challenges, including adjustments to the acquisition plan and temporary suspension of review by the Shanghai Stock Exchange [7][9] - For the first three quarters of 2025, Nanjing Shanglv reported revenue of 553 million, a year-on-year decline of 8.07%, and a net profit of 18.98 million, down 51.46% compared to the previous year [9]

Group 1 - The core viewpoint of the article is that two companies, Bohai Chemical and Nanjing Tourism, have announced the termination of significant asset restructuring plans due to various challenges and disagreements among involved parties [4][9][11] Group 2 - Bohai Chemical announced the termination of its major asset restructuring plan aimed at selling 100% of Bohai Petrochemical and acquiring control of Taida New Materials, primarily due to a lack of consensus on key terms among the parties involved [4][6][7] - The restructuring was intended to divest Bohai Chemical's loss-making propane dehydrogenation (PDH) business and transition towards fine chemicals, amidst ongoing financial struggles with continuous losses [7] - Bohai Chemical's financial performance shows revenues of 3.225 billion yuan, 4.784 billion yuan, and 2.809 billion yuan for 2023, 2024, and the first three quarters of 2025 respectively, with net losses of 522 million yuan, 632 million yuan, and 579 million yuan during the same periods [7] Group 3 - Nanjing Tourism decided to terminate its acquisition of 100% of Nanjing Huangpu Hotel due to changes in market conditions and other related factors, which were not specified [9][11] - The restructuring process for Nanjing Tourism began in May 2024 and faced multiple challenges, including adjustments to the acquisition plan and temporary halts for asset evaluations [11][12] - Nanjing Tourism reported a revenue decline of 8.07% to 553 million yuan and a net profit drop of 51.46% to 18.98 million yuan for the first three quarters of 2025, attributed to decreased income from tourism and trade businesses [11][12] Group 4 - Prior to the termination announcements, Bohai Chemical's stock surged by 22.87% over five trading days, reaching a market capitalization of 5.6 billion yuan [14] - Similarly, Nanjing Tourism's stock increased by over 45% in the 11 trading days leading up to the termination announcement, with a market capitalization of 4.53 billion yuan [16]

Core Viewpoint - Bohai Chemical has announced the termination of its major asset restructuring plan, which included the sale of 100% equity in Tianjin Bohai Petrochemical Co., Ltd. and the acquisition of control over Taida New Materials Co., Ltd. [1][2] Group 1: Termination of Restructuring - The restructuring plan was initiated on December 5, 2025, and lasted only two weeks before being terminated due to a lack of agreement on core terms among the parties involved [5][6] - The termination of the restructuring will not adversely affect the company's business operations or financial status, and the involved parties will not bear any liability for breach of contract [6] Group 2: Stock Performance - Prior to the suspension of trading, Bohai Chemical's stock price surged, reaching a limit up on December 5, with a cumulative increase of approximately 22.87% over five trading days, raising its market capitalization to 5.606 billion CNY [7][9] Group 3: Financial Performance - Bohai Chemical has faced operational challenges in recent years, with revenues of 3.225 billion CNY, 4.784 billion CNY, and 2.809 billion CNY for the first three quarters of 2023, 2024, and 2025 respectively, and net losses of 522 million CNY, 632 million CNY, and 579 million CNY during the same periods [9] Group 4: Taida New Materials Overview - Taida New Materials, established in 1999, specializes in the research, development, manufacturing, and sales of heavy aromatic oxidation products, with its main product being trimellitic anhydride (TMA) [9][10] - The global TMA market has seen significant price increases, with prices rising from 19,000 CNY/ton to 50,000 CNY/ton following the permanent closure of production capacity by a major competitor [9] - Taida New Materials reported a revenue of 1.167 billion CNY in 2024, a year-on-year increase of 146.02%, and a net profit growth of 1112.41% [9]

| 2026未来产业新材料博览会 | （FINE），围绕机器人、汽车、无人机、数据中心、航空航天、AI、新能 | | --- | --- | | 源等未来产业共性需求，特设6大展区，其中 | 轻量化高强度与可持续材料展区 聚焦 | | 碳纤维、高分子和改性塑料、发泡材料等 | ， 欢迎咨询： | | 18957804107 | | 【DT新材料】 获悉， 12月19日， 渤海化学 公告称，公司决定 终止筹划 出售 渤海石化 100%股权、通过发行股份及支付现金的方式购买 泰达新材 控制权的重大 资产重组事项。由于双方未能就交易方案部分核心条款达成一致，交易各方协商一致决定终止筹划本次交易。 据悉，就在本月，12月5日， 渤海化学 发布公告宣布筹划上述大事，没想到半个月就终止了。 不过原本这次业务大腾挪操作就非常冒险，跟着周期起伏，可能一 直赶不上周期。 资料显示， 渤海化学 1993年12月6日在A股上市。控股股东是 渤化集团， 成立于1991年5月7日，注册资本超85.84亿元。 被出售的子公司， 渤海石化 ，成立于 2018年4月12日，注册地址位于天津市滨海新区，注册资本24.8亿元，其拥有一套年产60 ...

说句实在话，一家上市公司把97%的收入来源直接"砍掉"，这可不是普通调整，而是背水一战。 咱们今天聊的这事，主角是一家曾靠注入资产起死回生、如今又濒临退市边缘的老牌企业。 它现在想用一个"风口上"的新业务来续命，可问题是，这个新故事，真的能讲下去吗？ 断臂求生：三年亏17亿，只能赌一把 从2022年开始，这家公司的净利润就没见过正数，三年多累计亏损超17亿元。 核心业务是丙烷制丙烯，听起来高大上，实则被原材料和产品价格"两头夹击"：丙烷价格居高不下，丙 烯却卖不动价。 毛利率从2020年的20%一路滑到2025年前三季度的-12.18%，几乎每卖一吨都在亏钱。 周叔翻了翻财报，2025年上半年，它97.71%的营收都来自这家即将被卖掉的子公司。 换句话说，这不是优化资产，是彻底换血。 而推动这一切的，正是背后的地方国资——眼看着上市平台快保不住了，干脆来个"腾笼换鸟"。 押注TMA：踩在周期顶点上的豪赌 那么，新选中的"救命稻草"是谁？是一家主营偏苯三酸酐（TMA）的新三板公司。 这家公司过去两次冲击IPO都被否，理由很一致：毛利率高得离谱，又解释不清。 泰达新材业绩 但2024年，它突然"开挂"——净利润从 ...

前段时间，一则"年产8万吨聚苯硫醚（PPS）树脂项目正式破土动工"新闻刷屏，因为热门材料聚苯硫醚行业格局稳 定了很多年，这家出现突然，产能之大，一举要冲击全球第一地位！ 近日，背后的关联企业又迎来大动作。 【DT新材料】获悉，12月5日，渤海化学发布公告，公司正在筹划出售天津渤海石化有限公司100%股权、通过发行 股份及支付现金的方式购买安徽泰达新材料股份有限公司的控制权。本次交易预计构成重大资产重组，不会导致公 司实际控制人变更，不构成重组上市。公司股票自12月8日开市起停牌，预计停牌时间不超过10个交易日。 看似常见的资产"腾挪"，背后有多个"亮点"。 资料显示，渤海化学1993年12月6日在A股上市。控股股东是渤化集团，成立于1991年5月7日，注册资本超85.84亿 元。被出售的子公司，渤海石化，成立于2018年4月12日，注册地址位于天津市滨海新区，注册资本24.8亿元，其拥 有一套年产60万吨的PDH（丙烷脱氢制乙烯）装置，采用国际先进的Lummus Catofin工艺，正是渤海化学的核心。 11月22日，公司发布的公告显示，渤海石化的PDH装置原计划检修30天，但因需与新建项目进行联调联试，预计 ...

2026未来产业新材料博览会 （FINE），围绕机器人、汽车、无人机、数据中心、航空航天、AI、新能 源等未来产业共性需求，特设6大展区，其中 轻量化高强度与可持续材料展区 聚焦 碳纤维、高分子和改性塑料、发泡材料等 ， 欢迎咨询： 18957804107 前段时间，一则" 年产8万吨聚苯硫醚（PPS）树脂项目正式破土动工 "新闻刷屏，因为热门材料聚苯硫醚行业格局稳定了很多年，这家出现突然，产能之大，一 举要冲击全球第一地位！ 近日，背后的关联企业又迎来大动作。 点击阅读 ： PPS ，两大化工巨头再加码， 18 万吨新厂也正赶来！ 【DT新材料】 获悉，12月5日， 渤海化学 发布公告， 公司正在筹划出售 天津渤海石化有限公司 100%股权、通过发行股份及支付现金的方式购买 安徽泰达新材 料股份有限公司 的控制权。本次交易预计构成重大资产重组，不会导致公司实际控制人变更，不构成重组上市。公司股票自12月8日开市起停牌，预计停牌时间 不超过10个交易日。 看似常见的资产"腾挪"，背后有多个"亮点"。 资料显示， 渤海化学 1993年12月6日在A股上市。控股股东是 渤化集团， 成立于1991年5月7日，注册资 ...

记者丨江佩佩 见习记者张嘉钰 资料显示，天津渤海化学股份有限公司1993年12月6日在A股上市，公司的主营业务是聚丙烯、环氧丙烷、丙烯酸、丙烯腈等的生产。公司的主要产品 是基础化工产品。 近年来，渤海化学深陷亏损泥潭且亏损持续扩大，2022年至2024年归母净利润分别为-3823.78万元、-5.21亿元、-6.32亿元；2025年前三季度，公司归母 净利润为-5.79亿元，同比下滑7.85%，三年三季度合计亏损逾17.7亿元。 在连年亏损下，渤海化学开始谋求转型。在2024年年报中，公司表示谋划向新材料、高端专用化学品、绿色化学品方向转型。本次筹划收购泰达新材或 是其中一环。 编辑丨张楠 12月5日晚间，渤海化学(600800)发布公告称，公司正筹划出售渤海石化100%股权、通过发行股份及支付现金的方式购买泰达新材的控制权。公司股票 自12月8日起开始停牌，预计停牌时间不超过10个交易日。 值得一提的是，渤海化学股票"提前"涨停，二级市场方面，渤海化学近两日大涨，并于12月5日涨停，最新报收5.05元/股，市值为56.1亿元。 | < 日 | 渤海化学〔600800〕 | | | | | --- | --- ...

记者丨 江佩佩 见习记者张嘉钰 编辑丨张楠 12月5日晚间，渤海化学(600800)发布公告称，公司正筹划出售渤海石化100%股权、通过发行 股份及支付现金的方式购买泰达新材的控制权。公司股票自12月8日起开始停牌，预计停牌时 间不超过10个交易日。 值得一提的是，渤海化学股票"提前"涨停，二级市场方面，渤海化学近两日大涨，并于12月5 日涨停，最新报收5.05元/股，市值为56.1亿元。 近 年 来 ， 渤 海 化 学 深 陷 亏 损 泥 潭 且 亏 损 持 续 扩 大 ， 2022 年 至 2024 年 归 母 净 利 润 分 别 为-3823.78万元、-5.21亿元、-6.32亿元；2025年前三季度，公司归母净利润为-5.79亿元，同 比下滑7.85%，三年三季度合计亏损逾17.7亿元。 在连年亏损下，渤海化学开始谋求转型。在2024年年报中，公司表示谋划向新材料、高端专用 化学品、绿色化学品方向转型。本次筹划收购泰达新材或是其中一环。 公开资料显示，泰达新材成立于1999年，专业从事重芳烃氧化系列产品研究、开发、制造、销 售和进出口贸易，主导产品为偏苯三酸酐（简称TMA），下游应用领域包括增塑剂、 ...

Core Viewpoint - The price of trimellitic anhydride (TMA) has significantly dropped, losing over 72% from its peak last year, raising concerns about the viability of Changqing Technology's ambitious 10 billion TMA project amidst a challenging market environment [2][3]. Group 1: Market Conditions - In September 2025, the mainstream transaction price of TMA in East China fell to 15,500-15,600 yuan/ton, reflecting a drastic decline from previous highs [2][14]. - The price of TMA surged to over 50,000 yuan/ton in 2024 due to global supply disruptions, but has since plummeted, with a 50% drop noted from early 2025 [13][17]. - The TMA market is facing a potential oversupply as multiple companies are expanding production, leading to fears of a price drop and supply-demand imbalance by 2026 [12][19]. Group 2: Company Strategy and Financials - Changqing Technology initiated an 8 billion convertible bond financing for its TMA project, which was approved by shareholders on September 19 [2]. - The company’s total assets are only 2.56 billion yuan, while the first phase of the TMA project alone requires an investment of 3 billion yuan, raising concerns about financial sustainability [25]. - The company has reported a significant decline in revenue and net profit, with a year-on-year decrease of 10.67% and 31.89% respectively, indicating weakened profitability [25]. Group 3: Competitive Landscape - The closure of INEOS's TMA production facility has created a temporary supply gap, but the subsequent market response has led to aggressive expansions by domestic companies [6][8]. - Other companies like Zhengdan Co. and Baichuan Co. are also expanding their TMA production capacities, which could further saturate the market [9][12]. - The market's cautious sentiment towards Changqing Technology is reflected in its stock performance, with institutional holdings below 5%, contrasting with competitors like Zhengdan Co. which have higher institutional support [21][23].